Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion...
Keep Reading →
November 8 - Hedge Funds, News - Comments
William Leland Edwards‘ Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management. According to our calculations...
Keep Reading →
March 2 - Hedge Funds, News - Comments
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States...
Keep Reading →
December 1 - Hedge Fund Analysis, Hedge Funds, News - Comments
William Leland Edwards‘ Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that...
Keep Reading →
July 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1...
Keep Reading →
December 29 - Hedge Funds, News - Comments
Neal C. Bradsher’s BroadWood Capital disclosed yesterday the acquisition of 260,341 shares of STAAR Surgical Company (NASDAQ:STAA)’s Common Stock,...
Keep Reading →
November 5 - Hedge Funds, News - Comments
Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in. However, it’s the sector-specific...
Keep Reading →
October 20 - Hedge Funds, News - Comments
Jeremy Green‘s Redmile Group has also reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD), after yesterday, William Leland Edwards’...
Keep Reading →
October 9 - Hedge Funds, News - Comments
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD). According to...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they...
Keep Reading →
September 26 - Hedge Funds, News - Comments
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S. Securities and Exchange...
Keep Reading →
July 2 - Hedge Funds, News - Comments
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM). In a new filing with the Securities and Exchange Commission...
Keep Reading →
June 23 - Hedge Funds, News - Comments
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower...
Keep Reading →
May 27 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc. (...
Keep Reading →
March 7 - Hedge Funds, News - Comments
Samuel Isaly‘s Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on...
Keep Reading →
March 6 - Hedge Funds, News - Comments
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved...
Keep Reading →
January 16 - Hedge Funds, News - Comments
Kevin Kotler‘s Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed. Broadfin reported...
Keep Reading →
December 30 - Hedge Funds, News - Comments
William Leland Edwards‘ fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc...
Keep Reading →
November 12 - Hedge Funds, News - Comments
Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M. Geoffrey Parker, Senior Vice President and CFO at Anacor Pharmaceuticals...
Keep Reading →
October 7 - Insider Trading, News - Comments
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment...
Keep Reading →
September 17 - News - Comments
As fast as we can type this, Phill Gross and Robert Atchinson’s hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares...
Keep Reading →
September 9 - News - Comments
Is ABIOMED, Inc. (NASDAQ:ABMD) a good investment? In the 21st century investor’s toolkit, there are tons of gauges investors can use to track the equity...
Keep Reading →
September 5 - News - Comments
Should Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) investors track the following data? Now, according to many market players, hedge funds are assumed...
Keep Reading →
September 4 - News - Comments
What’s a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of...
Keep Reading →
September 3 - News - Comments
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age. Although there are over 8,000...
Keep Reading →
September 3 - News - Comments
Is it smart to be bullish on Sequenom, Inc. (NASDAQ:SQNM)? If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles...
Keep Reading →
August 30 - News - Comments
Should investors bullish on QLT Inc. (USA) (NASDAQ:QLTI) consider the following data? In the financial world, there are many indicators shareholders...
Keep Reading →
August 30 - News - Comments
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a good investment? In the eyes of many investors, hedge funds are seen as useless, outdated investment tools...
Keep Reading →
August 30 - News - Comments
Is Cyberonics, Inc. (NASDAQ:CYBX) a good investment? In today’s marketplace, there are a multitude of methods market participants can use to monitor...
Keep Reading →
August 29 - News - Comments
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge...
Keep Reading →
August 29 - News - Comments
Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era...
Keep Reading →
August 28 - News - Comments
To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times. Although there are more...
Keep Reading →
August 28 - News - Comments
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) investors: listen up. In today’s marketplace, there are a multitude of methods shareholders can use to watch...
Keep Reading →
August 27 - News - Comments
In the financial world, there are tons of metrics shareholders can use to analyze Mr. Market. A couple of the most innovative are hedge fund and insider...
Keep Reading →
August 26 - News - Comments
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time. Although there...
Keep Reading →
August 26 - News - Comments
STAAR Surgical Company (NASDAQ:STAA) was in 7 hedge funds’ portfolio at the end of March. STAA shareholders have witnessed a decrease in enthusiasm...
Keep Reading →
June 27 - News - Comments
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds’ portfolio at the end of March. CYTK shareholders have witnessed an increase in support from...
Keep Reading →
June 24 - News - Comments
XOMA Corp (NASDAQ:XOMA) investors should be aware of an increase in hedge fund interest recently. In the eyes of most stock holders, hedge funds are seen...
Keep Reading →
June 17 - News - Comments
Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood. The number of bullish hedge fund bets...
Keep Reading →
June 17 - News - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds’ portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm...
Keep Reading →
June 14 - News - Comments
